SEARCH

SEARCH BY CITATION

References

  • 1
    Jacyna MR, Thomas HC. Pathogenesis and treatment of chronic infection. In: ZuckermanAJ, ThomasHC, eds. Viral hepatitis scientific basis and clinical management. New York: Churchill Livingstone, 1993: 185205.
  • 2
    Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Meyer zum Büschenfelde K-H. Treatment of chronic type B Hepatitis with recombinant a-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989; 10: 2428.
  • 3
    Fattovich G, Betterle C, Brollo L, Pedini B, Giustina G, Realdi G, Alberti A, et al. Autoantibodies during a-interferon therapy for chronic hepatitis B. J Med Virol 1991; 34: 132135.
  • 4
    Weber P, Wiedmann K-H, Klein R, Blum HE, Berg PA. Induction of autoimmune phenomenon in patients with chronic hepatitis B treated with gamma-interferon. J Hepatol 1994; 20: 321328.
  • 5
    Burman P, Karlsson FA, Öberg K, Alm G. Autoimmune thyroid disease in interferon-treated patients. Lancet 1985; ii: 100101.
  • 6
    Schultz M, Muller R, von zur Möhlen A, Brabant G. Induction of hyperthy-roidism by interferon-α-2b. Lancet 1989; i: 1452.
  • 7
    Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985; i: 1166.
  • 8
    Talaymat A, Leventhal B, Sakarcan A, Kashima H, Monteiro C. Systemic lupus erythematosus in a child receiving long-term interferon therapy. J Pediatr 1992; 120: 429432.
  • 9
    Rönnblom LE, Alm GV, Öberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 151: 178183.
  • 10
    Akard LP, Hoffman R, Elias L, Saiers JH. Alpha interferon and immune haemolytic anaemia. Ann Intern Med 1986; 105: 306.
  • 11
    Abdi EA, Venner PM. Immune thrombocytopaenia after α-interferon therapy in patients with cancer. JAMA 1986; 255: 18781879.
  • 12
    Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW. Exacerba-tion of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990; 65: 22372242.
  • 13
    Silva MO, Reddy KJ, Jeffers LJ, Hill M, Schiff ER. Interferon-induced chronic active hepatitis? Gastroenterology 1991; 101: 840842.
  • 14
    Fagan EA, Guarner PA, Perera SDK, Trowbridge R, Rolando N, Davison F, Williams R. Quantitaten of hepatitis B virus DNA (HBV-DNA) in se-rum using the spot hybridization technique and scintillation counting. J Virol Methods 1985; 12: 251262.
  • 15
    Sternberg MJE., PROMOT: a “FORTRAN” program to scan protein se-quences against a library of known motifs. Comput Appl Biosci 1991; 7: 257260.
  • 16
    Kobayashi M, Koike K. Complete nucleotide sequence of hepatitis B virus DNA of s öb type adr and its conserved gene Organisation. Gene 1984; 30: 227232.
  • 17
    Holborow J, Johnson G. Antinuclear factor in systemic lupus erythematosus. A consideration of the immunofluorescent method of detecting antinu-clear antibodies, with results obtained in a family study. Arthritis Rheum 1964; 7: 119127.
  • 18
    Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819820.